Skip to main navigation
Skip to search
Skip to main content
University College Cork Home
Search content at University College Cork
Home
Profiles
Research units
Research output
Activities
Prizes
Datasets
Impacts
Courses
Press/Media
mRNA Delivery for Therapeutic Anti-HER2 Antibody Expression In Vivo
Y. Rybakova
,
Piotr S. Kowalski
, Yuxuan Huang
, John T. Gonzalez
, Michael W. Heartlein
, F. DeRosa
, Derfogail Delcassian
, Daniel G. Anderson
Massachusetts Institute of Technology
Translate Bio
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'mRNA Delivery for Therapeutic Anti-HER2 Antibody Expression In Vivo'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Immunology and Microbiology
In Vitro
100%
Trastuzumab
71%
Protein Expression
28%
Therapeutic Antibodies
28%
Pharmacokinetic
14%
Blood Level
14%
Biological Product
14%
Antineoplastic Activity
14%
Antibody Generation
14%
Biochemistry, Genetics and Molecular Biology
Messenger RNA
100%
Lipid
45%
Trastuzumab
45%
Protein Expression
18%
Therapeutic Antibodies
18%
Pharmacokinetic
9%
Blood Level
9%
Anticancer
9%
Tumor Progression
9%
Antineoplastic Activity
9%
Antibody Production
9%
Pharmacology, Toxicology and Pharmaceutical Science
Messenger RNA
100%
Nanoparticle
45%
Trastuzumab
45%
Malignant Neoplasm
18%
Neoplasm
9%
Tumor Growth
9%
Pharmacokinetic
9%
Combination Therapy
9%
Diseases
9%
Biological Product
9%